Early Cochlear Changes In Migrain With Transient Evoked Otoacoustic Emissions

Year 2018, Volume: 45 Issue: 4, 439 - 446, 13.12.2018

Mehmet Akdağ Eşref Akil

https://doi.org/10.5798/dicletip.468048

Cited By: 1

Abstract

Objective: In
this study, our objective is to examine the cochlear functions that might occur
during the early period of migraine.

Methods:
Our prospective study was planned as a clinical study and it was analyzed by
measuring the transient otoacoustic emission of individuals who have or do not
have migraine with normal audition limit as pure tone audiometry.

Results:
The emission amplitudes of the patients with migraine were lower than the
control group P < 0.05). Even though the difference at the frequency of 2.0
Hz on the right side was significant P < 0.05) in the statistical analysis
conducted between the patients and the control group, it was not found
significant at other frequencies (P >0.05). In addition, there were no
statistical differences between the patients with migraine and the control
groups in terms of gender and age (P >0.05).

Conclusion:
Audiologic monitorisation might be required in the long-term with larger
patient groups despite of the minimal changes in the cochlear function in the
early stages of migraine.

Keywords

Migraine, Transient Otoacoustic Emission Testing

References

• 1. Eggers SDZ and Zee DS. “Central vestibular disorders,” in Otolaryngology, Head and Neck Surgery, C. W. Cummings, P. W. Flint, L. A.Harker et al., Eds., vol. 4,2005: pp. 3254–3288, Mosby, St Louis, Mo, USA. 4th edition,
• 2. Olsson JE. Neurotologic findings in basilar migraine. Laryngoscope. 1991; 101: 11–1.
• 3. Virre ES, Baloh RW. Migraine as a cause of sudden hearing loss. Headache. 1996; 36: 24–28.
• 4. Lempert, T., Neuhauser, H. Epidemiology of vertigo, migraine and vestibular migraine. Journal of Neurology. 2009; 256: 333-38. 4. Karatas M. Migraine and vertigo. Headache research and treatment. 2011, Article ID 793672, 1-7.
• 5. Katsarava Z, Giffin N, Diener HC, Kaube H. Abnormal habituation of ‘nociceptive’ blink reflex in migraine. Evidence for increased excitability of trigeminal nociception. Cephalalgia. 2003; 23: 814–19.
• 6. Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain 1984; 107: 1123–42.
• 7. Wober C, Holzhammer J, Zeitlhofer J, Wessely P, Wober-Bingol C. Trigger factors of migraine and tension-type headache: Experience and knowledge of the patients. J Headache .Pain 2006; 7: 188–95.
• 8. Gupta R, Bhatia MS. Comparison of clinical characteristics of migraine and tension type headache. Indian J Psychiatry. 2011; 53: 134–39.
• 9. Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache. 2001; 41: 554–58.
• 10. Kemp DT. Otoacoustic emissions, traveling waves and cochlear mechanisms. Hear Res .1986; 22: 95-104.
• 11. The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia: an International Journal of Headache. 2013; 33: 629–808.
• 12. Probst R, Hauser R. Distortion product otoacoustic emissions in normal and hearing impaired ears. Am J Otolaryngol. 1990; 11: 236-43.
• 13. Marshall L, Heller LM. Reliability of transient-evoked otoacoustic emissions. Ear Hear.1996; 17: 237-56.
• 14. Bolay H, Bayazit YA, Gündüz B, et al. Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study. Cephalalgia. 2008; 28: 309–17.
• 15. Joffily L, de Melo Tavares de Lima MA, Vincent MB, Frota SM. Assessment of otoacoustic emission suppression in women with migraine and phonophobia. Neurol Sci. 2016; 37: 703-09.
• 16. Hamed SA, Youssef, AH, Elattar AM. Assessment of cochlear and auditory pathways in patients with migraine. American Journal of Otolaryngology–Head and Neck Medicine and Surgery. 2012; 33: 385–94.
• 17. Günbey E, Hayriye Karabulut H. The relationship between the migraıne and obstructıve nasal pathologies. Acta Medica Mediterranea. 2014; 30: 1249-53.
• 18. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med. 2002; 346: 257-70.
• 19. Murdin L, Premachandra P, Davies R. Sensory dysmodulation in vestibular migraine: an otoacoustic emission suppression study. Laryngoscope. 2010; 120: 1632–36.
• 20. Bernard PA, Stenstrom RJ. Fluctuating hearing losses in children can be migraine equivalents. Int J Pediatr Otorhinolaryngol. 1988; 16: 141-48.
• 21. Lee H, Lopez I, Ishiyama A, Baloh RW. Can migraine damage the inner ear? Arch Neurol. 2000; 57: 1631-34.
• 22. Olesen J. The İnternational Classification of Headache Disorders, 2nd edition: application to practice. Funct Neurol. 2005; 20: 61-68.
• 23. Lalanne MC, Doutremepuich C, Boj F, et al. Some hemostatic and hemorheological disorders in auditory and vestibular impairments. Thromb Re. 1992; 66: 787-91.
• 24. Einer H, Tengborn L, Axelsson A, et al. Sudden sensorineural hearing loss and hemostatic mechanisms. Arch Otolaryngol Head Neck Surg. 1994; 120: 526-40.
• 25. Cilento BW, Norton SJ, Gates GA. The effects of aging and hearing loss on distortion product otoacoustic emissions. Otolaryngol Head Neck Surg. 2003; 129: 382-89.
• 26. Scher AI, Terwindt GM, Picavet HS, et al. Cardiovascular risk factors in migraine: the GEM population-based study. Neurology. 2005; 64: 614-20.
• 27. Woodhouse A, Drummond PD. Mechanisms of increased sensitivity to noise and light in migraine headache. Cephalalgia. 1993; 13: 417-21.
• 28. Dash AK, Panda N, Khandelwal G, et al. Migraine and audiovestibular dysfunction: is there a correlation? Am J Otolaryngol. 2008; 29: 295-99.